Other Gastrointestinal Diseases

In 2015, annual health care expenditures for gastrointestinal diseases totaled $135.9 billion.¹ This included costs from generalized diseases like abdominal pain, as well as specific disease in the malignant, inflammatory, or infectious space. Diagnosis of disease, monitoring disease changes, and predicting response to treatment can be difficult due to the invasiveness of traditioanl approaches and inaccuracy of noninvasive approaches. Geneoscopy is bridging that gap by employing precision diagnostic approaches using RNA-based technology. We are actively conducting research in a variety of disease indications to improve the lives of patients suffering from gastrointestinal diseases.